Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Events, News and Seminars

International focus on our ovarian cancer research

International focus on our ovarian cancer research

In an exciting breakthrough, researchers from the Kolling Institute’s Bill Walsh Lab have identified..... Read more

Category: Research Excellence

Home grown ideas place physio in patients' hands

Home grown ideas place physio in patients' hands

New research is testing a new way to meet the rapidly growing demand for physiotherapy in our publi..... Read more

Category: New Treatment

Common medication may lower risk of “heartbreak”

Common medication may lower risk of “heartbreak”

RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common med..... Read more

Category: Research Excellence